[Abortion (author's transl)]

Zeitschrift Fur Geburtshilfe Und Perinatologie
|April 1, 1980
PubMed

Today the problem of abortion presents a fundamentally different aspect to the obstetrician in respect of causality, diagnosis and treatment, than 10 to 15 years ago. When giving advice to a pregnant woman at the beginning of treatment of a threatened abortion, or after abortion has taken place, it is important for the treating physician in the hospital and in obstetric practice to point out that according to recent studies conception of pregnancy does not necessary mean carrying the child to full term. With particular view to the mental encouragement and hope which a woman tries to find after an abortion, to enter into a new pregnancy, she must be told that recent studies have shown that only part of the pregnancies result in live births. Loss of a conceived pregnancy is mainly a matter of fate largely governed by chance, which she must share with many other women; that is to say, abortion is only very rarely due to an anatomic defect or to functional failure. The article explains the problems inherent in modern therapy of threatened abortion. By means of control of a fairly large group of patients treated by the author from impending abortion to actual birth, the article shows which chances apply to a woman admitted to hospital because of threatened abortion, of giving birth to a healthy child after appropriate treatment. Today the number of malformations in a group of patients with impending abortion and successful delivery, is in no way different from the internationally known standard of malformations after full-term pregnancy in a group of normal women.

Related Concept Videos

Translation01:37

Translation

Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.Translation Produces the Building Blocks of LifeProteins are called the...
Embryonic Stem Cells00:58

Embryonic Stem Cells

Embryonic stem (ES) cells are undifferentiated pluripotent cells, meaning they can produce any cell type in the body. This gives them tremendous potential in science and medicine since they can generate specific cell types for use in research or to replace body cells lost due to damage or disease.
Reproductive Cloning01:27

Reproductive Cloning

Reproductive cloning is the process of producing a genetically identical copy—a clone—of an entire organism. While clones can be produced by splitting an early embryo—similar to what happens naturally with identical twins—cloning of adult animals is usually done by a process called somatic cell nuclear transfer (SCNT).
Somatic Cell Nuclear Transfer
In SCNT, an egg cell is taken from an animal and its nucleus is removed, creating an enucleated egg. Then a somatic cell—any cell that is not a sex...
Fertilization01:38

Fertilization

During fertilization, an egg and sperm cell fuse to create a new diploid structure. In humans, the process occurs once the egg has been released from the ovary, and travels into the fallopian tubes. The process requires several key steps: 1) sperm present in the genital tract must locate the egg; 2) once there, sperm need to release enzymes to help them burrow through the protective zona pellucida of the egg; and 3) the membranes of a single sperm cell and egg must fuse, with the sperm...
Embryonic Stem Cells00:57

Embryonic Stem Cells

Embryonic stem (ES) cells were first discovered in mice in 1981 by Martin Evans. In 1998, James Thomson identified a method to isolate embryonic stem cells from humans. Human embryonic stem cells (hESCs) are obtained from 3-5 day old embryos that remain unused after an in vitro fertilization procedure.
ES cells are grown in a culture medium where they can divide indefinitely, creating ES cell lines. Under certain conditions, ES cells can differentiate, either spontaneously into a variety of...
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...